Gail McIntyre, PhD, DABT has over 25 years of experience in drug discovery and development. She led PPD’s Compound Partnering Group for 7 years and was SVP at Furiex, responsible for identifying, assessing and managing full development programs. Her expertise is in toxicology and translating preclinical data into the clinic.
Laura Bonifacio, PharmD, PhD, brings expertise in designing and driving early development programs that align corporate strategy and scientific goals. She manages multi-disciplinary operations teams for IND-enabling and clinical programs. She has experience in supporting successful investigational new drug and marketing applications.
Sailash Patel, MBA, is a seasoned leader in start-up and multinational companies with extensive experience in financial and organization planning, corporate strategy development, mergers and acquisitions, licensing, market research and business integration. He has supported transactions with an aggregate value of $2 billion.